Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 5799-5806

  Yang, Otto O ^a   Kalams, Spyros A ^a   Rosenzweig, Michael ^a   Trocha, Alicja ^a   Jones, Norman ^a   Koziel, Margaret ^a   Walker, Bruce D ^a   Johnson, R Paul ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; EPITOPE; HLA ANTIGEN CLASS 1;

ARTICLE; B LYMPHOCYTE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029793618     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.5799-5806.1996     Document Type: Article

References (44)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. H. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Ahearne, P. M., R. A. Morgan, M. W. Sebastian, D. P. Bolognesi, and K. J. Weinhold. 1995. Multiple CTL specificities against autologous HIV-1-infected BLCLs. Cell. Immunol. 161:34-41.
3. Beersma, M. F., M. J. Bijlmakers, and H. L. Ploegh. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455-4454.
4. Bevan, M. J., and T. J. Braciale. 1995. Why can't cytotoxic T cells handle HIV? Proc. Natl. Acad. Sci. USA 92:5765-5767.
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
7. Chen, Z. W., L. Shen, M. D. Miller, S. H. Ghim, A. L. Hughes, and N. L. Letvin. 1992. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J. Immunol. 149:4060-4066.
8. Coupar, B. E., M. E. Andrew, G. W. Both, and D. B. Boyle. 1986. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur. J. Immunol. 16:1479-1487.
9. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, R. K. Tenner, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362:359-362.
10. Fruh, K., K. Ahn, H. Djabellah, P. Sempe, P. M. van Endert, R. Tampe, P. A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature (London) 375:415-418.
11. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
12. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yowdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (London) 375:411-412.
13. Howcroft, T. K., K. Strebel, M. A. Martin, and D. S. Singer. 1993. Repression of MHC class I gene promoter activity by two-exon tat of HIV. Science 260:1320-1322.
14. Jacks, T., M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (London) 331:280-283.
15. Johnson, R. P., and B. Walker. 1994. Cytotoxic T lymphocytes in HIV infection: responses to structural proteins. Curr. Opin. Microbiol. Immunol. 189:35-63.
16. Johnson, R. P., S. A. Hammond, A. Trocha, R. F. Siliciano, and B. D. Walker. 1994. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. J. Virol. 68:3145-3153.
17. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512-1521.
18. Johnson, V. A., and B. D. Walker. 1990. HIV-infected cell fusion assay, p. 92-94. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York.
19. Kalams, S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. DAquila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
20. Kerkau, T., L. R. Schmitt, A. Schimpl, and E. Wecker. 1989. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res. Hum. Retroviruses 5:613-620.
21. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giagrande, R. E. Phillips, and A. J. McMichael. 1994. Naturally occurring HIV-1 gag variants antagonise cytotoxic T cell activity. Nature (London) 369:403-406.
22. Koenig, S., T. R. Fuerst, L. V. Wood, R. M. Woods, J. A. Suzich, G. M. Jones, V. F. de la Cruz, R. T. J. Davey, S. Venkatesan, B. Moss, et al. 1990. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J. Immunol. 145:127-135.
23. Koup, R. A. 1994. Virus escape from CTL recognition. J. Exp. Med. 180: 779-782.
24. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
25. Koup, R. A., J. L. Sullivan, P. H. Levine, D. Brettler, A. Mahr, G. Mazzara, S. McKenzie, and D. Panicali. 1989. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 73:1909-1914.
26. Koziel, M. J., D. Dudley, J. T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B. D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
27. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Stelgerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature (London) 375:685-688.
28. McElrath, M. J., M. Rabin, M. Huffman, S. Klucking, J. V. Garcia, and P. D. Greenberg. 1994. Evaluation of human immunodeficiency virus type 1 (HIV-1) cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1. J. Virol. 68:5074-5083.
29. Meyerhans, A., G. Dadaglio, J. P. Vartanian, D. P. Langlade, R. Frank, B. Asjo, F. Plata, and S. Wain-Hobson. 1991. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur. J. Immunol. 21:2637-2640.
30. Myers, G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1993. Human retroviruses and AIDS 1993: a compilation and analysis of nucleic and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.M.
31. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 362:355-358.
32. Phillips, R. E., J. S. Rowland, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (London) 354:453-459.
33. Piatak, M. J., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
34. Safrit, J., C. A. Andrews, Z. Tuofu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
35. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class 1 antigen expression in T-B lymphoblast hybrids. Immunogenetics 21: 235-246.
36. Scheppler, J. A., J. K. Nicholson, D. C. Swan, A. A. Ahmed, and J. S. McDougal. 1989. Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after HIV-1 infection. J. Immunol. 143:2858-2866.
37. Schwartz, O., V. Marechal, S. Le Gall, F. Lemonnier, and J.-M. Heard. 1996 Endocytosis of major histocompatibility complex class 1 molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:338-342.
38. Townsend, A., J. Bastin, K. Gouid, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I restricted cytotoxic T lymphocytes in vaccinia infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-1224.
39. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N, Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 180:1283-1293.
40. Walker, B. D., C. Flexner, L. K. Birch, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514-9518.
41. Walker, B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64-66.
42. Wold, W. S., and L. R. Gooding. 1989. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol. Biol. Med. 6:433-452.
43. Wong, J. T., and R. B. Colvin. 1987. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. J. Immunol. 139:1369-1374.
44. Yang, O. O., S. Kalams, A. Trocha, A. Luster, R. P. Johnson, B. D. Walker. Unpublished observations.